1 recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Recruiting 1 |
Follow EBV TCR-T: new trials by email Literature Review of EBV TCR-T trials Research Report on EBV TCR-T
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma EBV TCR-T - NK/T-cell Lymphoma, Peripheral T-cell Lymphoma (PTCL) | Early Phase 1 | Recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 24 | 2025-09-20 | 2025-12-02 |
Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, T-Cell, Peripheral (1)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)
China (1)
PMID 18042692, PMID 19880495, PMID 20671118, PMID 23023715, PMID 23649469, PMID 24142051, PMID 26202875, PMID 26222726, PMID 26353084, PMID 26424652, PMID 27269947, PMID 28911074, PMID 29920566, PMID 33242451, PMID 37781191